Related Experiment Video
Updated: Mar 26, 2026
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
Published on: August 22, 2025
Clinical/Therapeutic Approaches for Cannabinoid Ligands in Central and Peripheral Nervous System Diseases: Mini
Katarzyna Fijał1, Małgorzata Filip
1*Laboratory of Drug Addiction Pharmacology, Institute of Pharmacology, Polish Academy of Sciences; and †Faculty of Pharmacy, College of Medicine, Jagiellonian University, Kraków, Poland.
Objective:
Cannabinoids, the components of Cannabis sativa Linnaeus, interact with CB1 and CB2 receptors, which are located both in the central nervous system and in the periphery and thus may exert a widespread biological activity in the body. The main medicinal properties of cannabinoids include analgesic, anti-inflammatory, antitumor, appetite stimulation, antiemesis, and muscle relaxation effects. This mini review aims to explore existing clinical trials that investigated the use of cannabinoids in diseases affecting the nervous system.
Methods:
We reviewed recent studies of cannabinoid-based therapy for disorders affecting central and peripheral nervous system in human subjects.
Results:
There is evidence that cannabinoid-based drugs may effectively control some symptoms associated with nervous system dysfunction, especially various types of pain and neurologic disorders, although studies are limited.
Conclusions:
The efficacy of cannabinoid drugs in the treatment of nervous system diseases should be verified in future large-scale randomized clinical trials.
